Comparative study between Diclofenac 3% Cream and 17% Salicylic acid + 2.5% 5 fluorouracil cream in the treatment of Seborrheic Keratosis

Read full text Summarise with VIRAT
Authors: Hadeer Abouzeid AbdelKader, Amira Ahmed Abdelazim, Hala M. Elsadek
Cited by: 0
References: 13

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: Seborrheic keratoses (SKs) are frequently encountered skin growths in dermatological practice. Patients often seek their removal for cosmetic reasons, aiming to achieve a more youthful look.Objectives: This comparative study compared the efficacy and safety of diclofenac sodium 3% cream versus 17% salicylic acid combined with 2.5% 5-fluorouracil (5FU) cream for the treatment of SK. Thirty patients with raised seborrheic keratosis were enrolled in this randomized comparative study.Materials and Methods: Patients included in the study were recruited from the dermatology outpatient clinic at Al-Zahra University Hospital, from June 2023 to April 2024. Each patient was given two jars; a red jar containing diclofenac sodium 3% cream that was applied on one lesion twice daily for 8 weeks and a white jar containing 17% salicylic+2.5% 5FU in a cream base that was applied on another lesion at night. Patients were examined before treatment and every week of the treatment. Clinical assessment of patients involved grading SK using the Physician's Lesion Assessment (PLA) scale before and after treatment, in accordance with the Baumann Scaling System in addition to dermoscopic examination and Patient’s satisfaction.Results: The diclofenac 3% cream significantly reduced SK size, PLA scale and dermoscopic features. In addition, there were highly statistically significant color changes and an increase in patient satisfaction compared to the 17% salicylic + 2.5% 5FU.Conclusion: diclofenac sodium 3% cream is effective and safe in treatment of seborrheic keratosis with no side effects compared to 17% salicylic+2.5% 5-flurouracil cream.The study's limitations include a small sample size, a single concentration of diclofenac that restricts dose-related effect evaluation and the short follow-up period may not reflect long-term outcomes or recurrence.

Fields of Study & Subjects

Nonmelanoma Skin Cancer Studies Dermatologic Treatments and Research Cancer and Skin Lesions

Publication details

Journal / source
IP Indian Journal of Clinical and Experimental Dermatology
Volume
12
Issue
1
Pages
126–131
Publication date
18 March 2026
Language
EN